PRF Technologies Ltd.
PRFX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001801834
No open-market purchases or sales by PRF Technologies Ltd. insiders were filed in the last 90 days; 8 institutions reported holding it in 13F filings for Q2 2026, worth $280.6K in total; no superinvestor holds it.
Q1 2022 vs. Q4 2021
How the institutions holding PRF Technologies Ltd. changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Q1 2022 | Change |
|---|---|---|---|
| Holders | 8 | 6 | −2 |
| Shares | 133.8K | 98.4K | −35.4K (−26.4%) |
| Value | $178.0K | $122.0K | −$56.0K (−31.5%) |
New holders (2)
Institutions that held PRF Technologies Ltd. at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Empirical Financial Services, LLC d.b.a. Empirical Wealth Management | 30,000 | $37.0K | 0.00% |
| UBS Group AG | 7,406 | $9.00K | 0.00% |
Sold out (4)
Institutions that held PRF Technologies Ltd. at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Morgan Stanley | 27,608 | $37.0K |
| Susquehanna International Group, LLP | 25,528 | $34.0K |
| XTX Topco Ltd | 14,473 | $19.0K |
| Virtu Financial LLC | 12,150 | $16.0K |